头颈癌放化疗患者自发性吞咽频率的变化
这项前瞻性队列研究纳入80例接受放化疗的头颈癌患者,从基线随访至治疗后3个月,评估吞咽功能、进食、体重、吞咽频率、口干、疼痛和黏膜炎。多数指标呈抛物线下降,吞咽频率与口干至3个月未恢复;吞咽频率识别吞咽困难和经口摄入减少的AUROC分别为0.824和0.96。
要点
- 头颈癌放化疗期间多数吞咽相关指标呈抛物线下降。
- 吞咽频率和口干在治疗后3个月未显示恢复。
- 吞咽频率可较好识别治疗后吞咽困难和经口摄入减少。
核心结论
- 探索性研究提示自发性吞咽频率可能有助于识别头颈癌治疗后的吞咽困难。
- 自发性吞咽频率可能为放化疗全程吞咽功能变化提供简单客观的指标。
研究设计与样本
- 前瞻性队列研究,80例头颈癌患者从基线随访至放化疗后3个月。
- 在大学综合癌症中心评估吞咽功能、功能性饮食、体重、吞咽频率、口干、疼痛和黏膜炎。
- 采用单变量相关、t检验和重复测量方差分析评估关系。
- 通过AUROC和ROC曲线计算自发性吞咽频率诊断吞咽困难的准确性。
主要发现
- 多数指标在放化疗全程呈抛物线下降。
- 自发性吞咽频率和感知口干至3个月未显示恢复改善。
- 自发性吞咽频率与治疗后吞咽功能、口干、功能性饮食相关,并与3个月时疼痛相关。
- 自发性吞咽频率识别临床吞咽困难(MASA-C)的AUROC为0.824(95%CI,0.63-1.00),P<.0018。
- 自发性吞咽频率识别经口摄入减少(FOIS)的AUROC为0.96(95%CI,0.87-0.96),P<.0001。
临床怎么用
- 可考虑将自发性吞咽频率作为头颈癌放化疗患者吞咽功能变化的简单客观监测指标。
- 自发性吞咽频率可能辅助识别治疗后吞咽困难和经口摄入减少。
局限性
- 原文为探索性研究,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study sought to evaluate the role and trajectory of spontaneous swallowing frequency (SFA) in patients with head and neck cancer (HNC) undergoing chemoradiotherapy (C/RT).Study Design. Prospective cohort. SETTING: University comprehensive cancer center. METHODS: A prospective cohort of 80 patients with HNC was followed from baseline to 3 months post-C/RT. Subjects were evaluated for performance on swallowing function, functional diet consumed, weight, swallowing frequency rate, perceived xerostomia, perceived pain, and mucositis. Relationships were evaluated using univariate correlations, t tests, and repeated-measures analysis of variance. The diagnostic accuracy of SFA to express dysphagia was calculated by area under the curve (AUROC) and displayed using receiver operator characteristic curves. RESULTS: In general, patients with HNC demonstrated a parabolic decline in most measures over the C/RT trajectory. SFA and perceived xerostomia did not show improved recovery by 3 months. SFA was related to swallow function, xerostomia, and functional diet consumed posttreatment and pain at 3 months. The ability of SFA to correctly identify clinical dysphagia (Mann Assessment of Swallowing-Cancer version [MASA-C]) and reduced oral intake (Functional Oral Intake Scale [FOIS]) at posttreatment was strong (AUROC MASA-C: 0.824 [95% CI, 0.63-1.00], P < .0018; AUROC FOIS: 0.96 [95% CI, 0.87-0.96], P < .0001). CONCLUSION: This exploratory study suggests SFA may provide a useful method to identify dysphagia after HNC treatment. Furthermore, SFA may offer a simple, objective measure of swallowing function change in HNC over the C/RT trajectory.
引用
- Carnaby GD, Madhavan A, Barikroo A, et al. Change in Spontaneous Swallowing Frequency in HNC Patients Undergoing C/RT. Otolaryngol Head Neck Surg. 2021. PMID: 34154425. doi:10.1177/01945998211020744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。